Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 6/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propazine SCHEMBL9379274 | 0.89 | GAA (0.73) | GAATDP1LMNAHTTL3MBTL1 | |
| Propazine SCHEMBL9092745 | 0.89 | GAA (0.73) | GAATDP1LMNAHTTL3MBTL1 | |
| Atrazine SCHEMBL36936 | 0.89 | GAA (0.73) | GAATDP1LMNAHTTL3MBTL1 | |
| Atrazine SCHEMBL4306269 | 0.89 | GAA (0.73) | GAATDP1LMNAHTTL3MBTL1 | |
| Atrazine SCHEMBL1516439 | 0.89 | GAA (0.73) | GAATDP1LMNAHTTL3MBTL1 | |
| Propazine SCHEMBL29366712 | 0.89 | GAA (0.73) | GAATDP1LMNAHTTL3MBTL1 | |
| Atrazine SCHEMBL9117361 | 0.89 | GAA (0.73) | GAATDP1LMNAHTTL3MBTL1 | |
| Atrazine SCHEMBL29353679 | 0.89 | GAA (0.73) | GAATDP1LMNAHTTL3MBTL1 | |
| Atrazine SCHEMBL20723465 | 0.89 | GAA (0.73) | GAATDP1LMNAHTTL3MBTL1 | |
| Atrazine SCHEMBL20723443 | 0.87 | GAA (0.70) | GAATDP1LMNAHTTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1531670-B1 | HERBICIDAL COMPOSITION | SYNGENTA PARTICIPATIONS AG (CH) | 2015-12-09 | — | — | EP | disclosed |
| US-8551918-B2 | Herbicidal composition | SYNGENTA CROP PROTECTION LLC (US) | 2013-10-08 | — | — | US | disclosed |
| US-8097561-B2 | Herbicidal composition | SYNGENTA CROP PROTECTION, INC. (US) | 2012-01-17 | — | — | US | disclosed |
| US-20070197387-A1 | Herbicidal Composition | SYNGENTA PARTICIPATIONS AG (CH) | 2007-08-23 | — | — | US | disclosed |
| EP-1689227-A2 | HERBICIDAL COMPOSITION | Syngenta Participations AG (CH) | 2006-08-16 | — | — | EP | disclosed |
| EP-1531670-A4 | HERBICIDAL COMPOSITION | SYNGENTA PARTICIPATIONS AG (CH) | 2005-11-23 | — | — | EP | disclosed |
| US-20050233907-A1 | Herbicidal composition | SYNGENTA CROP PROTECTION AG (CH) | 2005-10-20 | — | — | US | disclosed |
| WO-2005055716-A2 | HERBICIDAL COMPOSITION | SYNGENTA PARTICIPATIONS AG (CH) | 2005-06-23 | — | — | WO | disclosed |
| EP-1531670-A1 | HERBICIDAL COMPOSITION | Syngenta Participations AG (CH) | 2005-05-25 | — | — | EP | disclosed |
| WO-2003105587-A1 | HERBICIDAL COMPOSITION | SYNGENTA PARTICIPATIONS AG (CH) | 2003-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050233907-A1 | Herbicidal composition | ADH5, ADH1C, AQP3 | GAA 1060/4885TDP1 4359/4885LMNA 3158/4885 |
| US-20070197387-A1 | Herbicidal Composition | DDT, HDHD5, DERL1 | GAA 652/4885TDP1 1427/4885LMNA 2553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.